Companies Dominating the IgE Allergy Blood Tests Market
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eurofins Viracor
- Neogen Corporation
- Omega Diagnostics PLC
- Abionic SA
- Amerimmune LLC
- AXO Science
- Biovator AB
- China Medical Technologies Inc
- Cytognos, SL
Browse Key Market Insights with Data Illustration:
In the News
- The U.S. Food & Drug Administration (FDA) has cleared Thermo Fisher Scientific's ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies. These cutting-edge blood tests, which are also anticipated to be made available countrywide, can serve as a diagnostic tool for physicians and other healthcare professionals by assisting in the identification of wheat and sesame allergies in patients who may experience a severe allergic reaction.
- Leading provider of immunology and infectious disease testing, Eurofins Viracor, officially opened its new, large laboratory in Lenexa, Kansas, today. With 215 current employees and 235 newly created roles, the 110,000 square foot, state-of-the-art facility will employ 450 people and provide additional capacity to support development in biopharma and transplant diagnostic testing services.
